Danish technology board investigates implants:
This article was originally published in Clinica
Executive Summary
The Danish board of technology, which assesses new technology and provides advice to the Danish parliament, has initiated a project investigating the use of implants in Denmark. According to EU regulations, if a product is accepted by a notified body in one EU country, then it must be accepted in all other member states. Unfortunately, claims the board, neither manufacturers not authorities in Denmark have confidence in this process. There is a large discrepancy between safety demands on new medicines and implants, especially in the area of post market surveillance, it says.
You may also be interested in...
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.